I alle undersøgelserne var Aldara mere effektivt end placebo. • Ved behandlingen af genitale vorter var den samlede fjernelsesprocent i de fire hovedundersøgelser 15 til 52% hos Aldara- behandlede patienter sammenlignet med 3 til 18% hos placebobehandlede patienter. • Når resultaterne af de to undersøgelser af basalcellekarcinomer blev sammenholdt, opnåedes der en fuldstændig fjernelse hos 66 til 80% af de Aldara- behandlede patienter sammenlignet med 0 til 3% i placebogruppen.
In all studies, Aldara was more effective than placebo. • In the treatment of genital warts, the total clearance rate across the four main studies was 15 to 52% in the Aldara-treated patients, compared with 3 to 18% in the placebo-treated patients. • When the results of the two studies in basal cell carcinoma were looked at together, total clearance was seen in 66 to 80% of Aldara-treated patients compared with 0 to 3% in the placebo group.